Detecting Alzheimer’s may soon require only a blood draw. New tests measure proteins that signal the disease’s hallmark plaques. They could bring early diagnosis within reach of routine care.
Proteins in blood
The signal is measurable. Blood levels of certain proteins track brain changes. Assays detect them.
Cheaper than scans
Access improves. Blood tests undercut costly brain imaging. Screening broadens.
Early detection
Timing helps. Catching disease early aids treatment. New drugs need it.
Accuracy rising
Performance improves. Tests increasingly match gold standards. Confidence grows.
Clinical caution
Limits remain. A positive test is not a diagnosis alone. Context matters.
Toward the clinic
Adoption nears. Labs prepare the tests for use. The path opens.
The bottom line
Blood tests measuring disease-linked proteins show promise for early Alzheimer’s detection, far cheaper than brain scans. They could enable timely treatment. Interpretation still requires clinical context.
